Notebook

Robert Walker (R-Pa.) surprised many of his colleagues both in and out of Congress with his December 15 announcement of plans to resign his seat when his term ends later this year. Walker, known as a staunch supporter of government-funded basic research, has headed the committee since 1995. He has also been a controversial figure, advocating merging federal science committees into a single cabinet-level agency. Many contend that Walker's departure will leave a void that will be difficult to fil

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

Robert Walker (R-Pa.) surprised many of his colleagues both in and out of Congress with his December 15 announcement of plans to resign his seat when his term ends later this year. Walker, known as a staunch supporter of government-funded basic research, has headed the committee since 1995. He has also been a controversial figure, advocating merging federal science committees into a single cabinet-level agency. Many contend that Walker's departure will leave a void that will be difficult to fill. National Science Foundation director Neal Lane applauds Walker's effort on behalf of securing dollars for the nation's basic research. "He'll be missed. NSF has enjoyed support from both sides of Congress. I expect he'll continue to push hard for federal science programs while he's in office," Lane says. "It's difficult to speculate what will happen after he leaves." Robert Park, director of public information for the American Physical Society in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies